Medicinska fakulteten

Organisation: fakultet

Fler filtreringsmöjligheter
  1. A Methodology for Assessment of Combined Effects of Particles and Noise on Humans During Controlled Chamber Exposure

    Wierzbicka, A., Albin, M., Andersson, U. B., Assarsson, E., Axmon, A., Barregård, L., Berglund, M., Bohgard, M., Broberg Palmgren, K., Brunskog, J., Gunnskog, A-T., Gudmundsson, A., Hagerman, I., Jönsson, B. A., Kåredal, M., Nilsson, P., Österberg, K., Pagels, J., Poulsen, T., Rissler, J. & 2 andra, Stockfelt, L. & Sällsten, G., 2010, I : IARA. s. 3F1

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  2. Health Effects of Combined Exposure to Diesel Particles and Traffic Noise - a Methodology for Controlled Chamber Study

    Wierzbicka, A., Albin, M., Andersson, U. B., Assarsson, E., Axmon, A., Barrregård, L., Berglund, M., Bohgard, M., Broberg Palmgren, K., Brunskug, J., Gunnskog, A-T., Hagerman, I., Jönsson, B. A., Kåredal, M., Nilsson, P., Österberg, K., Pagels, J., Poulsen, T., Rissler, J., Stockfelt, L. & 3 andra, Sällsten, G., Xu, Y. & Anders Gudmundsson, 2011.

    Forskningsoutput: KonferensbidragKonferenspaper, ej i proceeding/ej förlagsutgivet

  3. Exposure to Diesel Particles and Traffic Noise - Health Effects Assessed in Controlled Human Laboratory Study

    Wierzbicka, A., Xu, Y., Albin, M., Andersson, U. B., Assarsson, E., Axmon, A., Barregård, L., Berglund, M., Bohgard, M., Broberg Palmgren, K., Brunskog, J., Hagerman, I., Jönsson, B. A., Kåredal, M., Nilsson, P., Österberg, K., Pagels, J., Poulsen, T., Rissler, J., Stockfelt, L. & 3 andra, Sällsten, G., Hansen, Å. M. & Anders Gudmundsson, 2012.

    Forskningsoutput: KonferensbidragKonferenspaper, ej i proceeding/ej förlagsutgivet

  4. 334 A virtual accelerator for validation of an electron dose calculation module in the presence of inhomogeneities

    Wieslander, E. & Tommy Knöös, 2005, I : Radiotherapy and Oncology. 76, Suppl. 2, s. S152

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  5. Dose perturbation in the presence of metallic implants: treatment planning system versus Monte Carlo simulations.

    Wieslander, E. & Tommy Knöös, 2003, I : Physics in Medicine and Biology. 48, 20, s. 3295-3305

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Monte Carlo based verification of a beam model used in a treatment planning system

    Wieslander, E. & Tommy Knöös, 2008, Journal of Physics: Conference Series. IOP Publishing, Vol. 102. s. 012027

    Forskningsoutput: Kapitel i bok/rapport/Conference proceedingKonferenspaper i proceeding

  7. A virtual linear accelerator for verification of treatment planning systems

    Wieslander, E. & Tommy Knöös, 2000, I : Physics in Medicine and Biology. 45, 10, s. 2887-2896

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. In vitro toxicity of biomaterials determined with cell density, total protein, cell cycle distribution and adenine nucleotides

    Wieslander, A. P., Nordin, M. K., Hansson, B., Bo Baldetorp & Kjellstrand, P. T. T., 1993, I : Artificial Cells, Blood Substitutes, and Biotechnology. 21, 1, s. 63-70

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. Verification of Dose Calculation Algorithms in Treatment Planning Systems for External Radiation Therapy: A Monte Carlo Approach

    Wieslander, E., 2006, Medical Radiation Physics, Lund University.

    Forskningsoutput: AvhandlingDoktorsavhandling (sammanläggning)

  10. The ability of the electrocardiogram in left bundle branch block to detect myocardial scar determined by cardiovascular magnetic resonance

    Wieslander, B., Xia, X., Robert Jablonowski, Axelsson, J., Klem, I., Nijveldt, R., Maynard, C., Schelbert, E. B., Sörensson, P., Sigfridsson, A., Uzma Chaudhry, Pyotr G. Platonov, Rasmus Borgquist, Henrik Engblom, Couderc, J. P., Strauss, D. G., Atwater, B. D. & Ugander, M., 2018 sep 1, I : Journal of Electrocardiology. 51, 5, s. 779-786 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Low dietary protein content alleviates motor symptoms in mice with mutant dynactin/dynein-mediated neurodegeneration.

    Wiesner, D., Sinniger, J., Henriques, A., Dieterlé, S., Müller, H-P., Rasche, V., Ferger, B., Dirrig-Grosch, S., Rana Soylu, Åsa Petersén, Walther, P., Linkus, B., Kassubek, J., Wong, P. C., Ludolph, A. C. & Dupuis, L., 2015, I : Human Molecular Genetics. 24, 8, s. 2228-2240

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. Chapter 7: Managing knowledge in evidence-based pharmacy

    Wiffen, P., Eriksson, T. & Lu, H., 2014, I : European Journal of Hospital Pharmacy: Science and Practice. 21, 6, s. 320-324

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  13. CHAPTER 3: Asking and formulating the right questions and finding useful resources in evidence-based pharmacy-2nd edition

    Wiffen, P., Eriksson, T. & Lu, H., 2014, I : European Journal of Hospital Pharmacy: Science and Practice. 21, 1, s. 2-6

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. Chapter 11: Getting a GRIP on pharmacy services

    Wiffen, P., Eriksson, T. & Lu, H., 2015, I : European Journal of Hospital Pharmacy: Science and Practice. 22, 5, s. 252-254

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. Chapter 10: Mentoring and teaching of evidence-based pharmacy

    Wiffen, P., Eriksson, T. & Lu, H., 2015, I : European Journal of Hospital Pharmacy: Science and Practice. 22, 4, s. 191-193

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. The tools of evidence-based medicine

    Wiffen, P., Eriksson, T. & Lu, H., 2014, I : European Journal of Hospital Pharmacy: Science and Practice. 21, 2, s. 74-78

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. CHAPTER 1 Ensuring pharmacy practice is fit for purpose in Evidence-based Pharmacy 2nd edition

    Wiffen, P., Eriksson, T. & Lu, H., 2013, I : European Journal of Hospital Pharmacy: Science and Practice. 20, 5, s. 308-312

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  18. Chapter 5: Appraising the evidence

    Wiffen, P., Eriksson, T. & Lu, H., 2014, I : European Journal of Hospital Pharmacy: Science and Practice. 21, 3, s. 134-138

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. CHAPTER 2 introduction to evidence-based practice in evidence-based pharmacy 2nd edition

    Wiffen, P., Eriksson, T. & Lu, H., 2013, I : European Journal of Hospital Pharmacy: Science and Practice. 20, 6, s. 324-327 4 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Glycosaminoglycans: a link between development and regeneration in the lung: a link between development and regeneration in the lung

    Wigén, J. C., Linda Elowsson Rendin, Karlsson, L., Emil Tykesson & Gunilla Westergren-Thorsson, 2019 jun 27, I : Stem Cells and Development. 28, 13, s. 823-832 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Phosphorylation of the oestrogen receptor alpha at serine 305 and prediction of tamoxifen resistance in breast cancer.

    Wigerup, C., Kok, M., Michalides, R., Fles, R., Koornstra, R., Wesseling, J., Hauptmann, M., Neefjes, J., Peterse, J., Stål, O., Landberg, G. & Linn, S., 2009, I : Journal of Pathology. 2008, Sep 23, s. 372-379

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift